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That’s nuts!
The prevalence of peanut allergy has nearly doubled in the 
past decade. The randomized, open-label, controlled LEAP 
(Learning Early about Peanut Allergy) trial, which enrolled 
640 infants with atopic disease, was conducted to determine 
whether the early introduction of dietary peanuts would pre-
vent peanut allergy, in light of evidence that avoidance of 
peanuts during infancy was not quelling this development. 
Du Toit and colleagues reported that the prevalence of pea-
nut allergy at 60 months was dramatically lower in the con-
sumption group (1.9%) than in the avoidance group (13.7%). 
In the intention-to-treat population that originally exhibited 
positive allergic response to peanuts, the prevalence of pea-
nut allergy was 70% lower in the consumption group. Thus, 
early introduction of peanuts significantly decreases the fre-
quency of peanut allergy development among children at 
risk, and, as evidenced by the higher levels of peanut-specif-
ic IgG4 antibody in the consumption group, early exposure 
also modulated the immune responses to peanuts. (New Engl 
J Med 372:803–13, 2015) Selected by M. Amagai
Gut feeling
Recently, Chassaing and colleagues published an eye-
opening report demonstrating that the commonly used food 
emulsifiers carboxymethylcellulose (CMC) and polysor-
bate-80 (P80) alter the gut microbiota in mice. Normally, 
the gut microbiota provides an important benefit to the 
host, although perturbation of this relationship may under-
lie  disease. Indeed, wild-type mice fed CMC or P80 exhib-
ited  low-grade inflammation and obesity/metabolic syn-
drome, whereas susceptible host mice exhibited robust coli-
tis  following treatment with these emulsifiers. Furthermore, 
microbiota encroachment on epithelial cells, altered bacte-
rial species composition, and increased proinflammatory 
potential were observed in these mice. These data indicate 
that emulsifiers disturb the host–microbiota relationship 
and result in a microbiota with enhanced mucolytic and 
proinflammatory activity that promotes intestinal inflam-
mation that may manifest as colitis or metabolic syndrome. 
Moreover, these studies, which clearly require repeating in 
humans, suggest that testing food additives is not sufficient 
and that these  additives may have contributed to the post-
mid-twentieth-century increase in inflammatory bowel dis-
ease, metabolic  syndrome, and other inflammatory diseases. 
(Nature 519:92–6, 2015) Selected by M. Amagai
Quorum forum
Coordinated organ behavior in response to an injury is 
essential for survival. In the hair follicle system, Chen and 
colleagues demonstrated that organ-level quorum sensing, 
a social behavior in which population decisions depend on 
the density of signaling to generate a response, facilitates 
hair regeneration via a multistep process in response to hair 
plucking in mice. First, plucking leads to hair keratinocyte 
apoptosis and inflammatory changes, including the overex-
pression of the inflammatory diffusible cytokine CCL2, which 
recruits M1 macrophages in the dermis. These motile inflam-
matory cells then secrete tumor necrosis factor-α, which is 
known to activate hair cycle regeneration. In this manner, 
each hair follicle serves as an individual sensor to assess 
the level of damage and, via coupling of molecular signals, 
both cytokines and motile inflammatory cells, a bottom-up 
quorum sensing response results in hair regeneration. (Cell 
161:277–90, 2015) Selected by J. Uitto
IL-4 silences IL-23
The canonical type 2 cytokine IL-4 inhibits autoimmune 
delayed-type hypersensitivity reactions, although the mecha-
nism of this suppression is not entirely clear. Guenova and 
colleagues recently found that IL-4 selectively suppresses 
IL-23 transcription and secretion by antigen-presenting cells 
while concomitantly inducing IL-12. This selective inhibition 
also impaired induction and maintenance of the pathogenic 
T helper type 17 (Th17) cells. These investigators r eported 
that IL-4 therapy for psoriasis, which is characterized by 
the absence of IL-4 and prevailing Th1 and Th17 cells in the 
skin, in humans also specifically suppressed IL-23 produc-
tion and Th17 cells without affecting the potentially protec-
tive IL-12/Th1 response. These findings support selective 
IL-4-mediated IL-23/Th17 silencing as a promising treatment 
against harmful inflammation without detrimentally affecting 
the potentially protective IL-12/Th1 arm of immunity, which 
is involved in the response against intracellular parasites and 
perhaps cancer. (Proc Natl Acad Sci USA 112:2163–8, 2015) 
Selected by T. Schwarz
Molecular skin map
The skin, which comprises molecules derived from our skin 
cells, our microbiota, and the environment, is an inter-
face between internal molecular processes and the exter-
nal environment. In an effort to understand the interplay 
of these components on the surface, Bouslimani and col-
leagues developed an approach to visualize the chemical 
and microbial community composition of human skin using 
three-dimensional topographical maps. Samples from one 
male and one female volunteer were obtained from approxi-
mately 400 sites and were subjected to mass spectrometry 
and 16S rRNA amplicon analysis. The roadmap generated 
using computer-assisted integrative analysis represents the 
highest spatial resolution available to date for both chemi-
cal and bacterial distributions. These maps revealed that the 
molecular composition of skin has diverse distributions and 
that not only skin cells and microorganisms, but also hygiene 
and beauty products define these compositions. These maps 
will ultimately facilitate study of specific chemical driv-
ers involved in modulation of the skin ecosystem and the 
impacts on human health and disease. (Proc Natl Acad Sci 
USA 112:E2120–9, 2015) Selected by S. Yuspa
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